The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.
Hartford Healthcare HLS IA HIAHX
- NAV / 1-Day Return 18.05 / +0.17 %
- Total Assets 140.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.920%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Health
- Investment Style Large Growth
- Min. Initial Investment —
- Status Open
- TTM Yield 0.43%
- Turnover 28%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0
Morningstar’s Analysis HIAHX
Will HIAHX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 44.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 12.55 | 17.4 Mil | Healthcare |
UnitedHealth Group Inc | 6.81 | 9.4 Mil | Healthcare |
Merck & Co Inc | 5.61 | 7.8 Mil | Healthcare |
Danaher Corp | 3.57 | 4.9 Mil | Healthcare |
Boston Scientific Corp | 3.33 | 4.6 Mil | Healthcare |
Thermo Fisher Scientific Inc | 2.82 | 3.9 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 2.58 | 3.6 Mil | Healthcare |
Stryker Corp | 2.43 | 3.4 Mil | Healthcare |
HCA Healthcare Inc | 2.39 | 3.3 Mil | Healthcare |
AbbVie Inc | 2.26 | 3.1 Mil | Healthcare |